Skip to content

CalAmp CAMP Net Investment in Lease

Net Investment in Lease at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
CytomX Therapeutics logo
CytomX TherapeuticsCTMX

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's net investment in lease?
CalAmp (CAMP) reported net investment in lease of $363K in Q1 2026.
How has CalAmp's net investment in lease changed year-over-year?
CalAmp's net investment in lease decreased by 93.4% year-over-year, from $5.54M to $363K.
What is the long-term trend for CalAmp's net investment in lease?
Over 2 years (2023 to 2025), CalAmp's net investment in lease has grown at a -77.4% compound annual growth rate (CAGR), from $7.76M to $397K.